Stay updated with breaking news from Mark Bleackley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), ('Incannex' or the 'Company') a clinical-stage pharmaceutical company developing unique...
Australia's Incannex (ASX: IHL) has been given the go-ahead for a clinical trial involving a formulation containing CBD and HCQ.
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has received ethics approval from the Bellberry Human Research Ethics Committee (HREC) to start the phase 1...
Highlights: Bellberry human research ethics committee approved the phase 1 clinical trial investigating safety and pharmacokinetics of IHL-675A on July 20,...
Incannex Healthcare (ASX: IHL) has collared ethics approval, which was the final regulatory hurdle before starting a phase 1 clinical trial of its multi-use anti-inflammatory drug IHL-675A.